Primary bone and joint tuberculosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:645822A18.0,
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Primary bone and joint tuberculosis, also known as osteoarticular tuberculosis, is an extrapulmonary form of tuberculosis caused by infection with Mycobacterium tuberculosis that primarily affects the skeletal system without a preceding or concurrent pulmonary focus. This condition accounts for approximately 10-35% of extrapulmonary tuberculosis cases. The infection most commonly involves the spine (Pott's disease or spinal tuberculosis), followed by the hip and knee joints, though any bone or joint can be affected. The disease results from hematogenous spread of the mycobacterium to bone and joint tissues, where it causes chronic granulomatous inflammation leading to progressive destruction of bone and cartilage. Key symptoms include chronic, insidious pain in the affected bone or joint, swelling, stiffness, and reduced range of motion. In spinal tuberculosis, patients may develop kyphotic deformity (gibbus), paravertebral abscess, and in severe cases, neurological complications including paraplegia due to spinal cord compression. Constitutional symptoms such as low-grade fever, night sweats, weight loss, and fatigue may be present but are not always prominent. Cold abscesses (without the typical signs of acute inflammation) and sinus tract formation are characteristic features. Joint involvement typically presents as a monoarticular arthritis with gradual onset. Diagnosis relies on a combination of clinical suspicion, imaging (X-rays, MRI, CT scans), microbiological confirmation through culture or PCR of tissue or aspirate samples, and histopathological examination showing caseating granulomas. Treatment consists of prolonged anti-tuberculosis chemotherapy, typically involving a combination of first-line drugs (isoniazid, rifampicin, pyrazinamide, and ethambutol) for an initial intensive phase of 2 months followed by a continuation phase of at least 4-6 months, though many experts recommend extended treatment of 9-12 months for bone and joint involvement. Surgical intervention may be necessary in cases of spinal instability, significant neurological deficit, large abscesses requiring drainage, or failure to respond to medical therapy. Early diagnosis and treatment are essential to prevent permanent skeletal deformity and disability.

Also known as:

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Primary bone and joint tuberculosis.

View clinical trials →

No actively recruiting trials found for Primary bone and joint tuberculosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Primary bone and joint tuberculosis community →

No specialists are currently listed for Primary bone and joint tuberculosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Primary bone and joint tuberculosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Primary bone and joint tuberculosisForum →

No community posts yet. Be the first to share your experience with Primary bone and joint tuberculosis.

Start the conversation →

Latest news about Primary bone and joint tuberculosis

No recent news articles for Primary bone and joint tuberculosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Primary bone and joint tuberculosis

What is Primary bone and joint tuberculosis?

Primary bone and joint tuberculosis, also known as osteoarticular tuberculosis, is an extrapulmonary form of tuberculosis caused by infection with Mycobacterium tuberculosis that primarily affects the skeletal system without a preceding or concurrent pulmonary focus. This condition accounts for approximately 10-35% of extrapulmonary tuberculosis cases. The infection most commonly involves the spine (Pott's disease or spinal tuberculosis), followed by the hip and knee joints, though any bone or joint can be affected. The disease results from hematogenous spread of the mycobacterium to bone and